Left Atrial Function of COVID-19-recovered Patients During the Surge of Omicron Variants
ClinicalTrials.gov; 11/12/2023; TrialID: NCT06170307
Clinical Trial Register
| ICTRP | ID: ictrp-NCT06170307
ABSTRACT
Condition
COVID-19 PandemicIntervention
Diagnostic Test two-dimensional speckle tracking echocardiographyPrimary outcome:
Left atrial strainCriteria
Inclusion Criteria
- 1. Patients having been diagnosed with SARS-CoV-2 Omicron variant infection based on
real-time reverse-transcription polymerase chain reaction (RT-PCR) results; 2.
Asymptomatic or mild to moderate COVID-19 patients. 3.COVID-19 patients who came to
our hospital for echocardiography within 3 months after recovery.
Exclusion Criteria
- Patients with decreased left ventricular ejection fraction (less than 50%), left
ventricular segmental wall motion abnormalities, cardiomyopathy, severe valvular heart
disease, arrhythmia, thyroid dysfunction, pulmonary hypertension, past or current
pulmonary embolism, severe chronic obstructive pulmonary disease, malignancy/renal
failure (less than 30) ml/min) or poor cardiogram image quality were excluded from the
study.
Collection:
Clinical trial registers
Database:
ICTRP
Topics:
Variants
Year:
2023
Document Type:
Clinical Trial Register
Similar
MEDLINE
...
LILACS
LIS